The AIxBio field stands at a critical juncture where rapid capability advances are outpacing governance frameworks and safety measures. The next 18 months will likely prove pivotal in determining whether voluntary safety practices by AI companies, emerging evaluation frameworks, and international coordination efforts can keep pace with technological development.
AIxBio capabilities hold immense promise—but they also introduce unprecedented risks. The exploitation of AIxBio capabilities for harm is a plausible near-term risk—and the time for action is now. NTI | bio offers actionable recommendations for governments, industry leaders, and philanthropic organizations to prevent catastrophic misuse.
Biological Weapons Convention (BWC) States Parties have a critical window of opportunity to take concrete steps toward enhancing transparency and building confidence in compliance with the norm against biological weapons development.
NTI | bio partnered with Lattice Automation to design and pilot a standard for capturing and transmitting metadata.
Response by NTI to the U.S. government issued request for information (RFI) related to the Artificial Intelligence (AI) Action Plan outlined by President Donald Trump’s January 2025 Executive Order.
This essay collection is designed to encourage the exploration and identification of potential solutions to disincentivize states from developing or using biological weapons. The goal of this collection is to bridge theory and practical policy-relevant approaches to develop new approaches to invigorate international efforts to reduce biological threats.
The integration of artificial intelligence (AI) with the life sciences offers tremendous potential benefits to society, but advances in AI biodesign tools also pose significant risks of misuse, with the potential for global consequences.
New report from NTI | bio offers recommendations for urgent actions that leaders within government, industry, the scientific community, and civil society should take to safeguard AI-bio capabilities.
Testimony of Jaime M. Yassif at U.S. House Hearing on "Strengthening Biosafety and Biosecurity Standards: Protecting Against Future Pandemics"
A new NTI | bio report describes the status of benchtop DNA synthesis devices, explains the risks for biosecurity, and recommends action and oversight by governments, industry, and the scientific community.
Sign up for regular updates on innovative, real-world solutions to existential threats.
